Feasibility of NIRS-based neurofeedback training in social anxiety disorder: behavioral and neural correlates.
Adult
Attentional Bias
/ physiology
Facial Recognition
/ physiology
Fear
/ physiology
Feasibility Studies
Female
Humans
Male
Neurofeedback
/ methods
Phobia, Social
/ physiopathology
Pilot Projects
Prefrontal Cortex
/ physiopathology
Social Perception
Spectroscopy, Near-Infrared
Treatment Outcome
Young Adult
Attention bias
DlPFC
Laughter
Near-infrared spectroscopy
Social anxiety disorder
Journal
Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
30
07
2018
accepted:
04
11
2018
pubmed:
1
12
2018
medline:
18
8
2020
entrez:
1
12
2018
Statut:
ppublish
Résumé
Attention biases towards threat signals have been linked to the etiology and symptomatology of social anxiety disorder (SAD). Dysfunction of the dorsolateral prefrontal cortex (dlPFC) may contribute to attention biases in anxious individuals. The aim of this study was to investigate the feasibility of near-infrared spectroscopy (NIRS) neurofeedback (NF) training-targeting the dlPFC-and its effects on threat-related attention biases of individuals with SAD. 12 individuals with SAD participated in the NIRS-NF training lasting 6-8 weeks and including a total of 15 sessions. NF performance increased significantly, while the attention bias towards threat-related stimuli and SAD symptom severity decreased after the training. The individual increase in neurofeedback performance as well as the individual decrease in SAD symptom severity was correlated with decreased responses to social threat signals in the cerebral attention system. Thus, this pilot study does not only demonstrate that NIRS-based NF is feasible in SAD patients, but also may be a promising method to investigate the causal role of the dlPFC in attention biases in SAD. Its effectiveness as a treatment tool might be examined in future studies.
Identifiants
pubmed: 30498952
doi: 10.1007/s00702-018-1954-5
pii: 10.1007/s00702-018-1954-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1175-1185Références
J Anxiety Disord. 2001 May-Jun;15(3):147-59
pubmed: 11442135
J Cereb Blood Flow Metab. 2003 Jan;23(1):1-18
pubmed: 12500086
Behav Res Ther. 2003 Nov;41(11):1325-35
pubmed: 14527531
Psychophysiology. 2003 Jul;40(4):511-20
pubmed: 14570159
Neuroimage. 2007 Apr 1;35(2):625-34
pubmed: 17258472
Psychol Med. 2008 Jan;38(1):15-28
pubmed: 17976249
J Abnorm Psychol. 2009 Feb;118(1):89-99
pubmed: 19222317
Clin Psychol Rev. 2010 Mar;30(2):203-16
pubmed: 20005616
Cogn Affect Behav Neurosci. 2010 Mar;10(1):8-20
pubmed: 20233952
J Child Psychol Psychiatry. 2010 Aug;51(8):859-70
pubmed: 20456540
Neuroimage. 2011 Jan 15;54(2):919-27
pubmed: 20851195
Cogn Emot. 2012;26(2):282-99
pubmed: 21806384
Behav Cogn Psychother. 2012 Mar;40(2):193-204
pubmed: 22017797
Annu Rev Clin Psychol. 2012;8:189-217
pubmed: 22035241
JAMA Psychiatry. 2013 Jan;70(1):87-97
pubmed: 22945462
J Psychiatr Res. 2012 Dec;46(12):1627-34
pubmed: 23058446
Stroke. 2013 Apr;44(4):1091-8
pubmed: 23404723
Annu Rev Clin Psychol. 2013;9:249-74
pubmed: 23537485
Neuroimage. 2014 Jan 15;85 Pt 1:478-88
pubmed: 23578578
Biol Psychol. 2014 Jan;95:21-30
pubmed: 23714227
Neuroimage. 2014 Jan 15;85 Pt 1:92-103
pubmed: 23891905
Biol Psychiatry. 2014 Dec 15;76(12):946-52
pubmed: 24690113
PLoS One. 2014 Jun 11;9(6):e99815
pubmed: 24918625
Neurosci Biobehav Rev. 2015 Jan;48:22-34
pubmed: 25446951
J Psychiatr Res. 2015 Jan;60:178-84
pubmed: 25449927
Front Hum Neurosci. 2015 Jan 07;8:1038
pubmed: 25610390
Addict Biol. 2016 Jul;21(4):982-92
pubmed: 26096546
Dialogues Clin Neurosci. 2015 Sep;17(3):327-35
pubmed: 26487813
Brain Imaging Behav. 2017 Jun;11(3):915-924
pubmed: 27233784
Neuropsychologia. 2017 Feb;96:175-183
pubmed: 28095313
Appetite. 2017 May 1;112:188-195
pubmed: 28131758
Mod Probl Pharmacopsychiatry. 1987;22:141-73
pubmed: 2885745
Front Hum Neurosci. 2017 Sep 04;11:425
pubmed: 28928644
PLoS One. 2017 Nov 27;12(11):e0188024
pubmed: 29176893
Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95
pubmed: 8923116
Stat Med. 1997 Nov 30;16(22):2529-42
pubmed: 9403954